157 related articles for article (PubMed ID: 17077967)
1. Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.
Lee N; Rainer TH; Ip M; Zee B; Ng MH; Antonio GE; Chan E; Lui G; Cockram CS; Sung JJ; Hui DS
Eur J Clin Microbiol Infect Dis; 2006 Dec; 25(12):765-72. PubMed ID: 17077967
[TBL] [Abstract][Full Text] [Related]
2. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?
Muller MP; Tomlinson G; Marrie TJ; Tang P; McGeer A; Low DE; Detsky AS; Gold WL
Clin Infect Dis; 2005 Apr; 40(8):1079-86. PubMed ID: 15791504
[TBL] [Abstract][Full Text] [Related]
3. Features discriminating SARS from other severe viral respiratory tract infections.
Rainer TH; Lee N; Ip M; Galvani AP; Antonio GE; Wong KT; Chan DP; Ng AW; Shing KK; Chau SS; Mak P; Chan PK; Ahuja AT; Hui DS; Sung JJ
Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):121-9. PubMed ID: 17219094
[TBL] [Abstract][Full Text] [Related]
4. Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.
Lui G; Ip M; Lee N; Rainer TH; Man SY; Cockram CS; Antonio GE; Ng MH; Chan MH; Chau SS; Mak P; Chan PK; Ahuja AT; Sung JJ; Hui DS
Respirology; 2009 Nov; 14(8):1098-105. PubMed ID: 19818051
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia.
Esposito S; Bianchini S; Gambino M; Madini B; Di Pietro G; Umbrello G; Presicce ML; Ruggiero L; Terranova L; Principi N
BMC Pulm Med; 2016 Jul; 16(1):103. PubMed ID: 27439403
[TBL] [Abstract][Full Text] [Related]
7. Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever.
Liu CL; Lu YT; Peng MJ; Chen PJ; Lin RL; Wu CL; Kuo HT
Chest; 2004 Aug; 126(2):509-17. PubMed ID: 15302738
[TBL] [Abstract][Full Text] [Related]
8. Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.
Bhuiyan MU; Blyth CC; West R; Lang J; Rahman T; Granland C; de Gier C; Borland ML; Thornton RB; Kirkham LS; Martin A; Richmond PC; Smith DW; Jaffe A; Snelling TL
BMC Pulm Med; 2019 Apr; 19(1):71. PubMed ID: 30940126
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin in severe acute respiratory syndrome (SARS).
Chua AP; Lee KH
J Infect; 2004 May; 48(4):303-6. PubMed ID: 15066330
[TBL] [Abstract][Full Text] [Related]
10. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
[TBL] [Abstract][Full Text] [Related]
11. The role of viruses in the aetiology of community-acquired pneumonia in adults.
Angeles Marcos M; Camps M; Pumarola T; Antonio Martinez J; Martinez E; Mensa J; Garcia E; Peñarroja G; Dambrava P; Casas I; Jiménez de Anta MT; Torres A
Antivir Ther; 2006; 11(3):351-9. PubMed ID: 16759052
[TBL] [Abstract][Full Text] [Related]
12. Differentiation between mycoplasma and viral community-acquired pneumonia in children with lobe or multi foci infiltration: a retrospective case study.
Guo WL; Wang J; Zhu LY; Hao CL
BMJ Open; 2015 Jan; 5(1):e006766. PubMed ID: 25596200
[TBL] [Abstract][Full Text] [Related]
13. Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.
Yoon NB; Son C; Um SJ
Ann Lab Med; 2013 Mar; 33(2):105-10. PubMed ID: 23482854
[TBL] [Abstract][Full Text] [Related]
14. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
[TBL] [Abstract][Full Text] [Related]
15. Commercial Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG CoV Extended Panel and ID NOW COVID-19 Test.
Jin R; Pettengill MA; Hartnett NL; Auerbach HE; Peiper SC; Wang Z
Arch Pathol Lab Med; 2020 Nov; 144(11):1303-1310. PubMed ID: 32649229
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia.
Tian J; Xu Q; Liu S; Mao L; Wang M; Hou X
Curr Med Res Opin; 2020 Nov; 36(11):1747-1752. PubMed ID: 32986475
[TBL] [Abstract][Full Text] [Related]
17. Clinical and radiological findings of adult hospitalized patients with community-acquired pneumonia from SARS-CoV-2 and endemic human coronaviruses.
Baek MS; Cha MJ; Kim MC; Chung JW; Kim WY; Choi H; Choi SH
PLoS One; 2021; 16(1):e0245547. PubMed ID: 33444422
[TBL] [Abstract][Full Text] [Related]
18. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
[TBL] [Abstract][Full Text] [Related]
19. The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia.
Huijskens EGW; Koopmans M; Palmen FMH; van Erkel AJM; Mulder PGH; Rossen JWA
J Med Microbiol; 2014 Mar; 63(Pt 3):441-452. PubMed ID: 24344207
[TBL] [Abstract][Full Text] [Related]
20. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
